GlassScriptPhysician profile
David Cheskis
NPI 1316471493
$9,262.35
in general payments reported to CMS, 2019-2025
28 companies · $1,498 in 2025
The $1,498 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $212 · 2021: $4,640 · 2022: $2,113 · 2023: $520 · 2024: $279 · 2025: $1,498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661 · Travel and Lodging: $636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.29 |
| Travel and Lodging | $636.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $3,799.14 | 2021-2022 | |
| Arthrex, INC. | $1,387.84 | 2021 | |
| Stryker Corporation | $1,100.58 | 2020-2025 | Augment Injectable, Swanson, Ortholoc 2 Lapifuse |
| Treace Medical Concepts, INC. | $1,063.62 | 2021-2025 | |
| Smith+Nephew, INC. | $485.15 | 2021-2024 | Collagenase Santyl, Grafix Pl |
| Amgen INC. | $207.57 | 2024-2025 | Krystexxa |
| Nevro Corp. | $159.89 | 2021-2024 | Senza |
| Royal Biologics, INC. | $112.44 | 2021 | |
| Bioventus LLC | $108.35 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Grt US Holding, INC. | $89.24 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $80.53 | 2021-2022 | |
| Cardiovascular Systems INC. | $76.09 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $75.64 | 2022-2023 | Seglentis |
| Dynasplint Systems INC. | $68.43 | 2023 | Dynasplint |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $58.38 | 2020-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $54.69 | 2023 | |
| Orthofix Medical, INC. | $53.70 | 2025 | Physio-Stim |
| Next Science LLC | $53.18 | 2023 | Xperience, Surgx, Blastx |
| Medtronic, INC. | $37.21 | 2022 | |
| Mimedx Group, INC. | $28.39 | 2025 | |
| Abbvie INC. | $26.82 | 2022 | |
| Paratek Pharmaceuticals, INC. | $23.66 | 2023 | Nuzyra |
| Polaris Technology Solutions LLC | $22.74 | 2024 | |
| Organogenesis INC. | $21.86 | 2022 | |
| Kci USA, INC. | $20.06 | 2022 | |
| Alfasigma USA, INC. | $19.52 | 2022 | |
| Tactile Systems Technology INC | $15.84 | 2025 | Nimbl, Flexitouch Plus |
| Fidia Pharma USA INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cheskis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.